Clinical Trial Update: Hedgehog Inhibition for Pancreatic Ductal Adenocarcinoma (PDAC) in the Preoperative Setting (HIPPoS) [Phase 2]

View source ↗

Summary

A Phase 2 trial investigating Hedgehog pathway inhibition for pancreatic ductal adenocarcinoma in the preoperative setting has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Ductal Adenocarcinoma

Snippet

Sponsor: Lisa Bax | Conditions: Pancreatic Ductal Adenocarcinoma | Phase 2 | Status: TERMINATED